Probiotics improve functional performance in patients with osteoarthritis: a randomized placebo-controlled clinical trial.

IF 4.3 2区 医学 Q2 NUTRITION & DIETETICS
Asima Karim, Haroon Ahmed Khan, Firdos Ahmad, Rizwan Qaisar
{"title":"Probiotics improve functional performance in patients with osteoarthritis: a randomized placebo-controlled clinical trial.","authors":"Asima Karim, Haroon Ahmed Khan, Firdos Ahmad, Rizwan Qaisar","doi":"10.1007/s00394-025-03805-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Osteoarthritis (OA), a progressive joint degeneration, significantly impairs people's ability to perform everyday tasks. Currently, there are no treatment options to cure OA.</p><p><strong>Objective: </strong>To explore the potential of probiotics to improve functional performance in OA patients.</p><p><strong>Trial design: </strong>This study follows a single-center, double-blinded, randomized, placebo-controlled clinical trial design.</p><p><strong>Method: </strong>Computer-based randomization assigned 60-75 years old 115 OA patients randomly into placebo (n = 55) and probiotics (n = 60) groups. The probiotic treatment was Vivomix 112 billion, one capsule daily to assess probiotic efficacy within a 16-week timeframe. The analysis included measurements of pain intensity with a visual analog scale, oxford knee score (OKS), knee flexion range of movement (ROM), short physical performance battery (SPPB), gait speed, handgrip strength (HGS), zonulin as a marker of intestinal permeability, c-reactive protein (CRP) as markers of inflammation and 8-isoprostanes for oxidative stress. Two measurements at baseline and after 16 weeks were recorded.</p><p><strong>Results: </strong>14 patients discontinued probiotic treatment, and six patients discontinued placebo intake, therefore, 95 patients, including placebo (n = 49) and probiotics (n = 46) groups, were analyzed. Probiotics significantly reduced plasma zonulin and pain intensity during walking, alongside notable improvements in OKS scores, ROM, gait speed, HGS, and SPPB scores compared to baseline in the probiotics group (all p < 0.05). The probiotic supplement significantly lowered CRP levels. Correlation analysis showed a robust association of % changes in plasma zonulin with OKS scores (r<sup>2</sup> = 0.294, p < 0.0001), SPPB total (r<sup>2</sup> = 0.233, p = 0.0007), and HGS (r<sup>2</sup> = 0.322, p < 0.0001).</p><p><strong>Conclusion: </strong>Multistrain probiotics enhances functional ability in OA patients; changes in zonulin suggest a possible link to intestinal permeability, though causality remains to be established.</p>","PeriodicalId":12030,"journal":{"name":"European Journal of Nutrition","volume":"64 7","pages":"290"},"PeriodicalIF":4.3000,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nutrition","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00394-025-03805-8","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Osteoarthritis (OA), a progressive joint degeneration, significantly impairs people's ability to perform everyday tasks. Currently, there are no treatment options to cure OA.

Objective: To explore the potential of probiotics to improve functional performance in OA patients.

Trial design: This study follows a single-center, double-blinded, randomized, placebo-controlled clinical trial design.

Method: Computer-based randomization assigned 60-75 years old 115 OA patients randomly into placebo (n = 55) and probiotics (n = 60) groups. The probiotic treatment was Vivomix 112 billion, one capsule daily to assess probiotic efficacy within a 16-week timeframe. The analysis included measurements of pain intensity with a visual analog scale, oxford knee score (OKS), knee flexion range of movement (ROM), short physical performance battery (SPPB), gait speed, handgrip strength (HGS), zonulin as a marker of intestinal permeability, c-reactive protein (CRP) as markers of inflammation and 8-isoprostanes for oxidative stress. Two measurements at baseline and after 16 weeks were recorded.

Results: 14 patients discontinued probiotic treatment, and six patients discontinued placebo intake, therefore, 95 patients, including placebo (n = 49) and probiotics (n = 46) groups, were analyzed. Probiotics significantly reduced plasma zonulin and pain intensity during walking, alongside notable improvements in OKS scores, ROM, gait speed, HGS, and SPPB scores compared to baseline in the probiotics group (all p < 0.05). The probiotic supplement significantly lowered CRP levels. Correlation analysis showed a robust association of % changes in plasma zonulin with OKS scores (r2 = 0.294, p < 0.0001), SPPB total (r2 = 0.233, p = 0.0007), and HGS (r2 = 0.322, p < 0.0001).

Conclusion: Multistrain probiotics enhances functional ability in OA patients; changes in zonulin suggest a possible link to intestinal permeability, though causality remains to be established.

益生菌改善骨关节炎患者的功能表现:一项随机安慰剂对照临床试验。
目的:骨关节炎(OA),一种进行性关节变性,严重损害人们执行日常任务的能力。目前,还没有治疗OA的方法。目的:探讨益生菌改善OA患者功能表现的潜力。试验设计:本研究采用单中心、双盲、随机、安慰剂对照临床试验设计。方法:将60-75岁的115例OA患者随机分为安慰剂组(n = 55)和益生菌组(n = 60)。益生菌治疗是Vivomix 1120亿,每天一粒胶囊,在16周的时间框架内评估益生菌的功效。分析包括使用视觉模拟量表测量疼痛强度,牛津膝关节评分(OKS),膝关节屈曲活动范围(ROM),短物理性能电池(SPPB),步态速度,握力(HGS), zonulin(肠通透性标志物),c-反应蛋白(CRP)(炎症标志物)和8-异前列腺素(氧化应激标志物)。记录基线和16周后的两次测量。结果:14例患者停止益生菌治疗,6例患者停止安慰剂治疗,共纳入95例患者,包括安慰剂组(n = 49)和益生菌组(n = 46)。与基线相比,益生菌组的OKS评分、ROM、步态速度、HGS和SPPB评分均有显著改善(均p = 0.294, p = 0.233, p = 0.0007), HGS评分也有显著改善(r2 = 0.322, p)。结论:多菌株益生菌可增强OA患者的功能能力;zonulin的变化可能与肠道通透性有关,但因果关系仍有待确定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.20
自引率
2.00%
发文量
295
审稿时长
6 months
期刊介绍: The European Journal of Nutrition publishes original papers, reviews, and short communications in the nutritional sciences. The manuscripts submitted to the European Journal of Nutrition should have their major focus on the impact of nutrients and non-nutrients on immunology and inflammation, gene expression, metabolism, chronic diseases, or carcinogenesis, or a major focus on epidemiology, including intervention studies with healthy subjects and with patients, biofunctionality of food and food components, or the impact of diet on the environment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信